Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
Homo sapiens |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Rattus norvegicus |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Danio rerio |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Drosophila melanogaster |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
ALK tyrosine kinase receptor (also known as anaplastic lymphoma kinase, ALK) is a neuronal orphan receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system [].ALK transduces signals from ligands at the cell surface, through specific activation of the mitogen-activated protein kinase (MAPK) pathway. Following activation by ligand, ALK induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1 [, , ]. ALK acts as a receptor for ligands pleiotrophin (PTN), a secreted growth factor, and midkine (MDK), a PTN-related factor, thus participating in PTN and MDK signal transduction. PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation [, ]. MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction []. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Publication |
First Author: |
Motegi A |
Year: |
2004 |
Journal: |
J Cell Sci |
Title: |
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. |
Volume: |
117 |
Issue: |
Pt 15 |
Pages: |
3319-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Degoutin J |
Year: |
2007 |
Journal: |
FEBS Lett |
Title: |
ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation. |
Volume: |
581 |
Issue: |
4 |
Pages: |
727-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Orthofer M |
Year: |
2020 |
Journal: |
Cell |
Title: |
Identification of ALK in Thinness. |
Volume: |
181 |
Issue: |
6 |
Pages: |
1246-1262.e22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stoica GE |
Year: |
2001 |
Journal: |
J Biol Chem |
Title: |
Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. |
Volume: |
276 |
Issue: |
20 |
Pages: |
16772-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Souttou B |
Year: |
2001 |
Journal: |
J Biol Chem |
Title: |
Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway. |
Volume: |
276 |
Issue: |
12 |
Pages: |
9526-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bowden ET |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. |
Volume: |
277 |
Issue: |
39 |
Pages: |
35862-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stoica GE |
Year: |
2002 |
Journal: |
J Biol Chem |
Title: |
Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. |
Volume: |
277 |
Issue: |
39 |
Pages: |
35990-8 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus |
Length: |
1621
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Vernersson E |
Year: |
2006 |
Journal: |
Gene Expr Patterns |
Title: |
Characterization of the expression of the ALK receptor tyrosine kinase in mice. |
Volume: |
6 |
Issue: |
5 |
Pages: |
448-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Degoutin J |
Year: |
2009 |
Journal: |
Eur J Neurosci |
Title: |
ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction. |
Volume: |
29 |
Issue: |
2 |
Pages: |
275-86 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Homo sapiens |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Homo sapiens |
|
•
•
•
•
•
|
Publication |
First Author: |
Lopez-Delisle L |
Year: |
2014 |
Journal: |
Oncotarget |
Title: |
Hyperactivation of Alk induces neonatal lethality in knock-in AlkF1178L mice. |
Volume: |
5 |
Issue: |
9 |
Pages: |
2703-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ono S |
Year: |
2019 |
Journal: |
Genesis |
Title: |
Generation of conditional ALK F1174L mutant mouse models for the study of neuroblastoma pathogenesis. |
Volume: |
57 |
Issue: |
10 |
Pages: |
e23323 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iwahara T |
Year: |
1997 |
Journal: |
Oncogene |
Title: |
Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. |
Volume: |
14 |
Issue: |
4 |
Pages: |
439-49 |
|
•
•
•
•
•
|
Publication |
First Author: |
Witek B |
Year: |
2015 |
Journal: |
PLoS One |
Title: |
Targeted Disruption of ALK Reveals a Potential Role in Hypogonadotropic Hypogonadism. |
Volume: |
10 |
Issue: |
5 |
Pages: |
e0123542 |
|
•
•
•
•
•
|
Publication |
First Author: |
Piva R |
Year: |
2006 |
Journal: |
Blood |
Title: |
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. |
Volume: |
107 |
Issue: |
2 |
Pages: |
689-97 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lopez-Delisle L |
Year: |
2018 |
Journal: |
Oncogene |
Title: |
Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis. |
Volume: |
37 |
Issue: |
11 |
Pages: |
1417-1429 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cazes A |
Year: |
2014 |
Journal: |
Oncotarget |
Title: |
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma. |
Volume: |
5 |
Issue: |
9 |
Pages: |
2688-702 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lu J |
Year: |
2017 |
Journal: |
Cancer Lett |
Title: |
The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model. |
Volume: |
400 |
|
Pages: |
61-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ouyang T |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA). |
Volume: |
278 |
Issue: |
32 |
Pages: |
30028-36 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus |
Length: |
151
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus |
Length: |
127
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Rattus norvegicus |
|
•
•
•
•
•
|
Author |
|
•
•
•
•
•
|
Publication |
First Author: |
Lasek AW |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
An evolutionary conserved role for anaplastic lymphoma kinase in behavioral responses to ethanol. |
Volume: |
6 |
Issue: |
7 |
Pages: |
e22636 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weiss JB |
Year: |
2012 |
Journal: |
Pharmacol Biochem Behav |
Title: |
Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis. |
Volume: |
100 |
Issue: |
3 |
Pages: |
566-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lovly CM |
Year: |
2014 |
Journal: |
Nat Med |
Title: |
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer. |
Volume: |
20 |
Issue: |
9 |
Pages: |
1027-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weiss JB |
Year: |
2017 |
Journal: |
Behav Brain Res |
Title: |
Pharmacological inhibition of Anaplastic Lymphoma Kinase rescues spatial memory impairments in Neurofibromatosis 1 mutant mice. |
Volume: |
332 |
|
Pages: |
337-342 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jamin Y |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Intrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastoma. |
Volume: |
9 |
Issue: |
3 |
Pages: |
e92886 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weiss JB |
Year: |
2017 |
Journal: |
Behav Brain Res |
Title: |
Genetic inhibition of Anaplastic Lymphoma Kinase rescues cognitive impairments in Neurofibromatosis 1 mutant mice. |
Volume: |
321 |
|
Pages: |
148-156 |
|
•
•
•
•
•
|
Publication |
First Author: |
Berry T |
Year: |
2012 |
Journal: |
Cancer Cell |
Title: |
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. |
Volume: |
22 |
Issue: |
1 |
Pages: |
117-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bilsland JG |
Year: |
2008 |
Journal: |
Neuropsychopharmacology |
Title: |
Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications. |
Volume: |
33 |
Issue: |
3 |
Pages: |
685-700 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chun MG |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis. |
Volume: |
107 |
Issue: |
40 |
Pages: |
17268-73 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Rattus norvegicus |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Rattus norvegicus |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Danio rerio |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Danio rerio |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
Danio rerio |
|
•
•
•
•
•
|
Publication |
First Author: |
Blasco RB |
Year: |
2014 |
Journal: |
Cell Rep |
Title: |
Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology. |
Volume: |
9 |
Issue: |
4 |
Pages: |
1219-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chiarle R |
Year: |
2008 |
Journal: |
Nat Med |
Title: |
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. |
Volume: |
14 |
Issue: |
6 |
Pages: |
676-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morris SW |
Year: |
1997 |
Journal: |
Oncogene |
Title: |
ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) |
Volume: |
14 |
Issue: |
18 |
Pages: |
2175-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Azarova AM |
Year: |
2011 |
Journal: |
Semin Cancer Biol |
Title: |
Emerging importance of ALK in neuroblastoma. |
Volume: |
21 |
Issue: |
4 |
Pages: |
267-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ueda T |
Year: |
2016 |
Journal: |
Oncogene |
Title: |
ALK(R1275Q) perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN. |
Volume: |
35 |
Issue: |
34 |
Pages: |
4447-58 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gonzalez Malagon SG |
Year: |
2018 |
Journal: |
Nat Commun |
Title: |
Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus. |
Volume: |
9 |
Issue: |
1 |
Pages: |
1126 |
|
•
•
•
•
•
|
Publication |
First Author: |
Martinengo C |
Year: |
2014 |
Journal: |
Cancer Res |
Title: |
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis. |
Volume: |
74 |
Issue: |
21 |
Pages: |
6094-106 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lange K |
Year: |
2003 |
Journal: |
Oncogene |
Title: |
Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice. |
Volume: |
22 |
Issue: |
4 |
Pages: |
517-27 |
|
•
•
•
•
•
|
Interaction Term |
|
•
•
•
•
•
|
Interaction Term |
|
•
•
•
•
•
|
Publication |
First Author: |
Reshetnyak AV |
Year: |
2015 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions. |
Volume: |
112 |
Issue: |
52 |
Pages: |
15862-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Heukamp LC |
Year: |
2012 |
Journal: |
Sci Transl Med |
Title: |
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. |
Volume: |
4 |
Issue: |
141 |
Pages: |
141ra91 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus musculus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus pahari |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5750208 |
Assay Type: |
Western blot |
Annotation Date: |
2016-02-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3267828 |
|
Stage: |
TS28 |
Assay Id: |
MGI:5750209 |
Age: |
postnatal adult |
|
|
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5750208 |
Assay Type: |
Western blot |
Annotation Date: |
2016-02-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3267828 |
|
Stage: |
TS28 |
Assay Id: |
MGI:5750209 |
Age: |
postnatal adult |
|
|
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5750208 |
Assay Type: |
Western blot |
Annotation Date: |
2016-02-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3267828 |
|
Stage: |
TS28 |
Assay Id: |
MGI:5750209 |
Age: |
postnatal adult |
|
|
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640080 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2006-08-08 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1611817 |
Pattern: |
Not Specified |
Stage: |
TS17 |
Assay Id: |
MGI:3640131 |
Age: |
embryonic day 10.5 |
|
|
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640080 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2006-08-08 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1611819 |
Pattern: |
Not Specified |
Stage: |
TS19 |
Assay Id: |
MGI:3640131 |
Age: |
embryonic day 11.5 |
|
|
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1698120 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 12.5 |
|
|
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1698121 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 13.5 |
|
|
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1698122 |
Pattern: |
Not Specified |
Stage: |
TS22 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 14.5 |
|
|
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1698120 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 12.5 |
Image: |
1f |
|
Detected: |
true |
Specimen Num: |
12 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1698121 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 13.5 |
|
|
Detected: |
true |
Specimen Num: |
28 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1698122 |
Pattern: |
Not Specified |
Stage: |
TS22 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 14.5 |
|
|
Detected: |
true |
Specimen Num: |
29 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3270420 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 12.5 |
|
|
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3270421 |
Pattern: |
Not Specified |
Stage: |
TS21 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 13.5 |
|
|
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3270422 |
Pattern: |
Not Specified |
Stage: |
TS22 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 14.5 |
|
|
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3270424 |
Pattern: |
Not Specified |
Stage: |
TS24 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 16.5 |
|
|
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640078 |
Assay Type: |
RNA in situ |
Annotation Date: |
2006-08-07 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:3270423 |
|
Stage: |
TS23 |
Assay Id: |
MGI:3640085 |
Age: |
embryonic day 15.5 |
|
|
Detected: |
false |
Specimen Num: |
30 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5750206 |
Assay Type: |
RNA in situ |
Annotation Date: |
2016-02-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3588326 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:5750210 |
Age: |
embryonic day 18.5 |
|
|
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5750206 |
Assay Type: |
RNA in situ |
Annotation Date: |
2016-02-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3588326 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:5750210 |
Age: |
embryonic day 18.5 |
|
|
Detected: |
true |
Specimen Num: |
7 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5750206 |
Assay Type: |
RNA in situ |
Annotation Date: |
2016-02-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3588326 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:5750210 |
Age: |
embryonic day 18.5 |
|
|
Detected: |
true |
Specimen Num: |
12 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5750206 |
Assay Type: |
RNA in situ |
Annotation Date: |
2016-02-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3588326 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:5750210 |
Age: |
embryonic day 18.5 |
|
|
Detected: |
true |
Specimen Num: |
13 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5750206 |
Assay Type: |
RNA in situ |
Annotation Date: |
2016-02-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3588327 |
Pattern: |
Not Specified |
Stage: |
TS27 |
Assay Id: |
MGI:5750210 |
Age: |
postnatal day 0 |
|
|
Detected: |
true |
Specimen Num: |
14 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4884532 |
Assay Type: |
RNA in situ |
Annotation Date: |
2011-04-11 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1691619 |
|
Stage: |
TS19 |
Assay Id: |
MGI:4945862 |
Age: |
embryonic day 11.5 |
Image: |
g01860 E11.5 |
|
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4884532 |
Assay Type: |
RNA in situ |
Annotation Date: |
2011-04-11 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1691623 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4945862 |
Age: |
embryonic day 15.5 |
Image: |
g01860 E15.5 |
Note: |
Expression was region specific and scattered. |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3640080 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2006-08-08 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1758320 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:3640131 |
Age: |
embryonic day 12.5 |
|
|
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|